Skip to main content
ClinicalTrials.govcontrolled

Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure

ClinicalTrials.gov study NCT02599480. IPD Sharing: YES. Countries: 8. Publications: 5.

ShareScore

32/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship
12
Harmonization
12
Access
0
Reuse readiness
0
Engagement
8

Topics

Dataset details

Repository
ClinicalTrials.gov
Published
February 11, 2026
License
IPD-YES
DOI
clinicaltrials.gov/NCT02599480

Scored with release 0.9.0

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.